Mechanical Bowel Preparation and Oral Antibiotics Versus Mechanical Bowel Preparation Only Prior Rectal Surgery
- Conditions
- Rectal AdenocarcinomaRectum NeoplasmColorectal NeoplasmsRectum CarcinomaColorectal CancerColorectal CarcinomaSurgical Site InfectionSurgery--Complications
- Interventions
- Drug: Oral AntibioticsDrug: PlaceboDrug: Mechanical Bowel Preparation
- Registration Number
- NCT04281667
- Lead Sponsor
- Helsinki University Central Hospital
- Brief Summary
MOBILE2 is a randomized controlled trial comparing mechanical and oral antibiotic bowel preparation to mechanical bowel preparation only in patients undergoing anterior rectal resection with primary anastomosis. Primary endpoint is Comprehensive Complication Index within 30 days from surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 604
- Patients scheduled for anterior rectal resection with primary anastomosis
- Emergency operation
- Bowel obstruction
- Existing stoma
- Other reason preventing mechanical bowel preparation
- Allergy to neomycin or metronidazole
- Age < 18 years
- Lack of co-operation
Exclusion criteria after randomization:
- Patient did not undergo surgery
- Anterior resection was not performed
- Colonic anastomosis was not performed
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Mechanical Bowel Preparation and Oral Antibiotics Oral Antibiotics Mechanical Bowel Preparation and Oral Antibiotics Mechanical Bowel Preparation and Oral Antibiotics Mechanical Bowel Preparation Mechanical Bowel Preparation and Oral Antibiotics Mechanical Bowel Preparation Only Placebo Mechanical Bowel Preparation Only Mechanical Bowel Preparation Only Mechanical Bowel Preparation Mechanical Bowel Preparation Only
- Primary Outcome Measures
Name Time Method Comprehensive Complication Index Within 30 days from surgery Comprehensive Complication Index score
- Secondary Outcome Measures
Name Time Method Surgical Site Infection Within 30 days from surgery Surgical site infection as defined by CDC
Lenght of hospital stay Within hospital stay, estimated on average 7 days Lenght of hospital stay
Mortality Within 90 days from surgery Mortality
Adjuvant therapy Within 6 months from surgery Patients receiving adjuvant therapy divided by patients needing adjuvant therapy
Anastomotic dehiscence Within 30 days from surgery Anastomotic dehiscence
Trial Locations
- Locations (3)
Turku University Hospital
🇫🇮Turku, Finland
Helsinki University Hospital
🇫🇮Helsinki, Finland
Tampere University Hospital
🇫🇮Tampere, Finland